Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model

Over 182 million confirmed cases of COVID-19 and more than 4 million deaths have been reported to date around the world. It is essential to identify broad-spectrum antiviral agents that may prevent or treat infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) but also by other...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsaidi, Sahar, Cornejal, Nadjet, Mahoney, Oneil, Melo, Claudia, Verma, Neeharika, Bonnaire, Thierry, Chang, Theresa, O’Keefe, Barry R., Sailer, James, Zydowsky, Thomas M., Teleshova, Natalia, Romero, José A. Fernández
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400000/
https://www.ncbi.nlm.nih.gov/pubmed/34436255
http://dx.doi.org/10.3390/md19080418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400000/
https://www.ncbi.nlm.nih.gov/pubmed/34436255
http://dx.doi.org/10.3390/md19080418

Ejemplares similares